Replimune Group, Inc.

NASDAQ:REPL

12.5 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Revenue 00000000
Cost of Revenue 2.6552.4474.5754.1391.8070.1480.1090.122
Gross Profit -2.655-2.447-4.575-4.139-1.807-0.148-0.109-0.122
Gross Profit Ratio 00000000
Reseach & Development Expenses 174.963126.52779.54556.75438.76122.17313.5166.936
General & Administrative Expenses 00023.20117.4378.7735.7132.711
Selling & Marketing Expenses 00000000
SG&A 59.8150.55338.76923.20117.4378.7735.7132.711
Other Expenses 0-5.676-1.059-0.665-0.0160.451-2.0560.626
Operating Expenses 234.773174.166115.14477.14853.11428.41816.9628.205
Operating Income -234.773-177.08-118.314-79.955-56.198-30.946-19.229-9.647
Operating Income Ratio 00000000
Total Other Income Expenses Net 19.3873.0840.278-0.9153.5730.112-0.4731.943
Income Before Tax -215.386-173.996-118.036-80.87-52.625-30.834-19.702-7.704
Income Before Tax Ratio 00000000
Income Tax Expense 0.4080.2881.1642.3951.9030.451-2.0560.125
Net Income -215.794-174.284-118.036-80.87-52.625-30.834-19.702-7.704
Net Income Ratio 00000000
EPS -3.24-2.99-2.26-1.75-1.54-1.33-0.64-0.36
EPS Diluted -3.24-2.99-2.26-1.75-1.54-1.33-0.64-0.25
EBITDA -230.198-170.303-114.408-76.478-52.597-28.27-16.853-8.083
EBITDA Ratio 00000000